These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8305649)
21. Patient-specific phosphorus mobilization clearance during nocturnal and short daily hemodialysis. Agar BU; Troidle L; Finkelstein FO; Kohn OF; Akonur A; Leypoldt JK Hemodial Int; 2012 Oct; 16(4):491-6. PubMed ID: 22574966 [TBL] [Abstract][Full Text] [Related]
22. Calcium-phosphate and parathyroid intradialytic profiles: A potential aid for tailoring the dialysate calcium content of patients on different hemodialysis schedules. Ferraresi M; Pia A; Guzzo G; Vigotti FN; Mongilardi E; Nazha M; Aroasio E; Gonella C; Avagnina P; Piccoli GB Hemodial Int; 2015 Oct; 19(4):572-82. PubMed ID: 25819092 [TBL] [Abstract][Full Text] [Related]
23. Postprandial Mineral Handling in Patients on Maintenance Hemodialysis. Reinhard M; Frystyk J; Randers E; Bibby BM; Ivarsen P J Ren Nutr; 2018 May; 28(3):175-182. PubMed ID: 29429792 [TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo. Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156 [TBL] [Abstract][Full Text] [Related]
25. Ranitidine clearance during hemodialysis with high-flux membrane: comparison of polysulfone and cellulose acetate hemodialyzers. Tsuruoka S; Sugimoto KI; Hayasaka T; Saito T; Fujimura A Eur J Clin Pharmacol; 2000 Nov; 56(8):581-3. PubMed ID: 11151748 [TBL] [Abstract][Full Text] [Related]
26. Circadian rhythm of serum phosphate, calcium and parathyroid hormone levels in hemodialysis patients. Micozkadioglu H; Ozelsancak R; Yildiz I; Erken E; Zumrutdal A; Torun D; Haberal M Clin Lab; 2013; 59(1-2):79-84. PubMed ID: 23505910 [TBL] [Abstract][Full Text] [Related]
27. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis. de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797 [TBL] [Abstract][Full Text] [Related]
28. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis? Mrowka C; Heintz B; Sieberth HG Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995 [TBL] [Abstract][Full Text] [Related]
30. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients. Tonelli M; Wang W; Hemmelgarn B; Lloyd A; Manns B; Am J Kidney Dis; 2009 Dec; 54(6):1108-15. PubMed ID: 19619920 [TBL] [Abstract][Full Text] [Related]
31. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study. Singh NP; Bansal R; Thakur A; Kohli R; Bansal RC; Agarwal SK Ren Fail; 2003 May; 25(3):419-30. PubMed ID: 12803505 [TBL] [Abstract][Full Text] [Related]
32. Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products (AGEs) and homocysteine metabolites. Klemm A; Franke C; Busch M; Müller A; Franke S; Lang D; Passlick-Deetjen J; Stein G Clin Nephrol; 2004 Mar; 61(3):191-7. PubMed ID: 15077870 [TBL] [Abstract][Full Text] [Related]
33. Postdialytic rebound of serum phosphorus: pathogenetic and clinical insights. Minutolo R; Bellizzi V; Cioffi M; Iodice C; Giannattasio P; Andreucci M; Terracciano V; Di Iorio BR; Conte G; De Nicola L J Am Soc Nephrol; 2002 Apr; 13(4):1046-1054. PubMed ID: 11912265 [TBL] [Abstract][Full Text] [Related]
34. Effect of dialysis membranes on lipoprotein profile of serum in haemodialysed patients. Kimak E; Solski J; Janicka L; Wojtysiak B; Zagojska M Int Urol Nephrol; 1998; 30(6):789-98. PubMed ID: 10195875 [TBL] [Abstract][Full Text] [Related]
35. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. Al-Hejaili F; Kortas C; Leitch R; Heidenheim AP; Clement L; Nesrallah G; Lindsay RM J Am Soc Nephrol; 2003 Sep; 14(9):2322-8. PubMed ID: 12937309 [TBL] [Abstract][Full Text] [Related]
36. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients. Zehnder C; Gutzwiller JP; Renggli K Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310 [TBL] [Abstract][Full Text] [Related]
37. Lack of relationship between parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure. Rudnicki M; McNair P; Transbøl I; Nielsen B Nephron; 1991; 58(2):144-9. PubMed ID: 1865969 [TBL] [Abstract][Full Text] [Related]
38. Phosphate Kinetics in Hemodialysis: Application of Delayed Pseudo One-Compartment Model. Poleszczuk J; Debowska M; Wojcik-Zaluska A; Ksiazek A; Zaluska W Blood Purif; 2016; 42(3):177-85. PubMed ID: 27304052 [TBL] [Abstract][Full Text] [Related]
39. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis. Schindler R; Marra MN; McKelligon BM; Lonnemann G; Schulzeck P; Schulze M; Oppermann M; Shaldon S Clin Nephrol; 1993 Dec; 40(6):346-51. PubMed ID: 7507806 [TBL] [Abstract][Full Text] [Related]
40. The influence of hemodialysis membranes on the plasma insulin level of diabetic patients on maintenance hemodialysis. Abe M; Kikuchi F; Kaizu K; Matsumoto K Clin Nephrol; 2008 May; 69(5):354-60. PubMed ID: 18538098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]